Crinetics Pharmaceuticals

For some patients undergoing treatment for acromegaly, gastrointestinal (GI) side effects may not be addressed. These side effects can interfere with daily life and significantly impact a patient’s overall well-being. Hear from #acromegaly patients about the GI side effects they experience during their treatment cycle: https://lnkd.in/d2aribMF

The current standard of care for treating #acromegaly can create an emotional impact for patients. It is important to recognize this impact and to account for the emotional needs of patients. Learn more about the emotional impact of acromegaly treatment on patients: https://lnkd.in/g4jBe9HW

Living with acromegaly presents unique challenges that require understanding, compassion, and a strong support system. This condition, characterized by excessive growth hormone production, can lead to significant health issues and impact daily life in profound ways. Hear first-hand accounts of the challenges faced by acromegaly patients and the vital role of a strong support system: https://bit.ly/3AIObsW

Acromegaly patients often endure a challenging treatment journey marked by persistent breakthrough symptoms. These symptoms, typically occurring at the end of a treatment cycle, can significantly impact a patient’s quality of life. Learn more about this #acromegaly treatment burden: https://bit.ly/3AukY4Z

At Crinetics, we believe patient-focused drug development is vital. From molecule to medicine, we value the patient’s voice and encourage patient input into our clinical development programs and beyond. Learn more about our patient advocacy efforts: https://lnkd.in/gSUMgvpG

Regular injections can be a painful part of managing acromegaly and can sometimes lead to uncomfortable reactions, making an already difficult journey even harder. Are you an #endocrinologist treating acromegaly? Learn more about how injection site pain may be impacting your patients: https://bit.ly/3WXRt4i

#CRNX announces second quarter 2024 earnings. Learn more: https://bit.ly/3WLaoOK

We are excited to announce the launch of ACRO/TRUTH, an educational initiative spotlighting the challenges faced by acromegaly patients managing their disease. This resource features authentic patient stories and data on injection site reactions, side effects, breakthrough symptoms, and the emotional impact of the current standard-of-care. ACRO/TRUTH is based on extensive interviews with patients, endocrinologists and leading patient organizations like Acromegaly Community. Learn more about this initiative: https://bit.ly/3YxHiEZ #AcromegalyAwareness #Endocrinology

Uncontrolled #acromegaly can have a debilitating impact on daily functioning and quality of life. Symptoms, such as fatigue and pain, are sometimes difficult to manage regularly. We’re focused on addressing this unmet need – and others – for people living with acromegaly. Learn more about our product candidate that we’re currently developing: https://bit.ly/4cTcdzP

For acromegaly patients on injectable somatostatin receptor ligands (SRLs), treatment-related symptoms and side effects can impair quality of life. Understanding the challenges people living with #acromegaly face is critical to improving their quality of life. Discover the truth about challenges faced by acromegaly patients: https://lnkd.in/gYgA7Kis